Indraprastha Medical Corporation Limited has reported Standalone financial results for the period ended September 30, 2021.
Financial Results (Q2 FY2022) - QoQ Comparison
The company has reported total income of Rs. 233.3630 crores during the period ended September 30, 2021 as compared to Rs. 203.1473 crores during the period ended June 30, 2021.
The company has posted net profit / (loss) of Rs. 12.0674 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 15.4402 crores for the period ended June 30, 2021.
The company has reported EPS of Rs. 1.32 for the period ended September 30, 2021 as compared to Rs. 1.68 for the period ended June 30, 2021.
Total Income | ₹ 233.3630 crs | ₹203.1473 crs | 14.87% |
Net Profit | ₹12.0674 crs | ₹15.4402 crs | -21.84% |
EPS | ₹1.32 | ₹1.68 | -21.43% |
Financial Results (Q2 FY2022) - YoY Comparison The company has reported total income of Rs. 233.3630 crores during the period ended September 30, 2021 as compared to Rs.141.2097 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.12.0674 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.0.4380 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.1.32 for the period ended September 30, 2021 as compared to Rs.0.05 for the period ended September 30, 2020.
Total Income | ₹ 233.3630 crs | ₹141.2097 crs | 65.26% |
Net Profit | ₹12.0674 crs | ₹0.4380 crs | 2,655.11% |
EPS | ₹1.32 | ₹0.05 | 2,540.00% |
Financial Results (Half Year Ended FY2022) - YoY Comparison The company has reported total income of Rs.436.5103 crores during the 6 Months period ended September 30, 2021 as compared to Rs.235.6277 crores during the 6 Months period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.27.5076 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.-24.7518 crores for the 6 Months period ended September 30, 2020.
The company has reported EPS of Rs.3 for the 6 Months period ended September 30, 2021 as compared to Rs.-2.70 for the 6 Months period ended September 30, 2020.
Total Income | ₹436.5103 crs | ₹235.6277 crs | 85.25% |
Net Profit | ₹27.5076 crs | ₹-24.7518 crs | 211.13% |
EPS | ₹3 | ₹-2.70 | 211.11% |
Shares of Indraprastha Medical Corporation Limited was last trading in BSE at Rs. 76.25 as compared to the previous close of Rs. 74.85. The total number of shares traded during the day was 11539 in over 368 trades.
The stock hit an intraday high of Rs. 76.95 and intraday low of 75.40. The net turnover during the day was Rs. 877804.00.
Source : Equity Bulls
Keywords
IndraprasthaMedicalCorporation
Q2FY22
H1FY22
ResultUpdate